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Abstract Inadequacies in health care practices have been
reported despite existing guidelines to manage hip or knee
osteoarthritis. To facilitate guideline implementation and
improve utilization of non-surgical treatment options a care
strategy should be developed. This study describes the
development of an evidence-based, multidisciplinary,
patient-centered, stepped care strategy. A national, multi-
disciplinary, steering group developed the strategy in three
phases: (1) consensus among steering group members (first
draft); (2) written consultation of 23 representatives of
patient organizations and professional associations involved
in osteoarthritis care (second draft); (3) consensus of the
final draft after discussion in two rounds during a
conference with representatives from the different disciplines.
The final stepped care strategy presents, in three tiers, the
optimal order for non-surgical treatment modalities. It
recommends that more advanced options should only
be considered if options listed in previous steps failed
to produce satisfactory results. Hence, the first step
treatment options can be offered to all patients but may
also be provided through self care (education, life style
advice, and acetaminophen). The second step (exercise
therapy, dietary therapy, and non-steroidal anti-inflammatory
drugs) and third step treatment options (multidisciplinary care,
intra-articular injections, and transcutaneous electrical nerve
stimulation) can be considered for people with persisting
complaints. Trough a consensus procedure, we succeeded to
develop a multidisciplinary, patient-centered, stepped care
strategy based on national guidelines. This strategy provides a
framework for health care providers and patients with hip or
knee osteoarthritis to discuss the optimal timing of the various
treatment options.
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Introduction
As there is no known cure for osteoarthritis (OA), treatment
is based on controlling pain, improving function, and
improving health-related quality of life. The potential of
the various non-surgical treatment modalities is clearly
demonstrated in several national and international guide-
lines to manage hip or knee OA [1–5]. In general, a
combination of pharmacological and non-pharmacological
treatment modalities is considered to be the best core
treatment. However, despite the availability of these guide-
lines inadequate diagnostic procedures, referrals, and
utilization of treatment modalities are seen in clinical
practice, leading to suboptimal outcomes.
A possible explanation for these inadequacies is the lack of
recommendations in current guidelines about the indication
for and the timing of treatment options, which over time can
impede optimal OA management. This explanation is
supported by the findings that only 28% of OA patients who
are scheduled to undergo total hip arthroplasty had actually
ever been referred to a physical therapist during their OA
history [6], and that non-pharmacological treatment options,
such as patient education, weight reduction and exercise
therapy are underutilized [7–10].
Another possible explanation is the poor incorporation of
guideline recommendations in clinical practice. For example,
half of the primary care physicians ordered inappropriate
diagnostic tests in a hypothetical patient with knee OA [9].
Furthermore, interventions lacking evidence for efficacy
(e.g., massage, traction, and stretching) are still utilized in
approximately half of the OA patients who received
physiotherapy [11].
To facilitate guideline implementation and improve
utilization of non-surgical treatment options, a multidisci-
plinary and patient-centered approach is suggested, as
different health care providers are involved in the non-
surgical care of OA, and a central role of the patient in
managing health in collaboration with providers is advo-
cated [12–15]. This multidisciplinary and patient-centered
approach could best be achieved by employing a “stepped”
care model. A stepped care model provides a good
framework for both health care providers as patients, as it
presents the optimal order when a range of interventions is
available and it uses limited resources to their greatest effect
[16, 17]. For these reasons, it appeared most suitable to
manage a heterogenic population like OA patients for a
prolonged period. The first step of such a model suggests
interventions that should be tried initially, while interven-
tions in later steps are reserved for those whose condition
was not controlled by lower step treatment options. Thus,
health care providers play an active role in monitoring and
evaluating the previous performed treatment options. This
model has been proven to be effective for several other
chronic disorders, like diabetes mellitus [18], depression
[19], and back pain [20].
To date, a few tools have been developed for health care
providers to support decision making in the OA manage-
ment. For instance, some clinical pathways describe
diagnostic procedures and OA management [13], but lack
recommendations about the timing for the different treat-
ment modalities. While Porcheret et al. [21] did develop a
stepped care strategy for older adults in primary care with
knee pain or knee OA, there is no such comprehensive
protocol to guide non-surgical management for patients
with hip or knee OA.
In the Netherlands, therefore, several stakeholders took
the initiative to develop a stepped care strategy [22], which
takes into account the diverse presentation and progression
of symptoms with the subsequent variation in treatment
needs. This article describes the developmental process and
the content of the multidisciplinary patient-centered,
stepped care strategy for hip or knee OA, known as BART,
i.e., Beating osteoARThritis.
Methods
The stepped care strategy was developed by a steering
group in three phases. This steering group, appointed by the
B&JD NL board, consisted of a patient representative and
six experts representing the main disciplines involved in
OA care: rheumatology (TPMV), orthopaedic surgery
(BAS), primary care (SMAB, TBV), physiotherapy
(CHME) and rehabilitation (JD).
The first phase started with studying the content of
national and international guidelines and performing a
literature search to identify recently published systematic
reviews about the management of OA, not incorporated in
guidelines. The steering group discussed and defined, in
several meetings, the starting points, in order to set a
preliminary focus for the content of the stepped care
strategy. Finally, the steering group formulated a first draft
of the stepped care strategy on the basis of consensus after
an open broad discussion in which differences were
resolved by discussion.
In the second phase, 23 representatives of patient
organizations and professional associations involved in
OA care were asked to comment to a set of questions (see
Table 1) on the first draft, by means of a written
consultation (20 responded). These questions were used to
aid the process of consensus by generating ideas for
comments and suggestions. Subsequently, the steering
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group summarised these comments and suggestions. Based
on these results, a second draft of the stepped care strategy
was made after differences were resolved by discussion.
Finally, during an invitational conference participants could
give feedback on these results in two discussion rounds led by
the chairman (TBV). Both rounds were performed by five
panels. In the first round homogenous groups were made: one
panel consisted of patient representatives and four panels of
four different disciplines (general practitioners (GPs), physical
therapists, orthopaedic surgeons and rheumatologists). After the
first round the chairman made in a plenary session an inventory
and summary of the main concerns and suggestions for change
raised by the different panels. Then, those concerns and
suggestions for change were discussed in a second round with
five mixed panels. In the second plenary session, consensus
was reached on the final version of the stepped care strategy.
Developmental process
Starting points
The steering group decided to build a three-step care strategy,
each step consisting of recommendations for the timing of
diagnostic procedures, treatment modalities, and evaluation.
First, they reached consensus about the following starting
points:
& The stepped care strategy is primarily based on the
Dutch multidisciplinary guideline for the diagnosis and
management of hip or knee OA [1]. While there is
general consistency in the numerous recommendations
among national and international guidelines as well as
among monodisciplinary and multidisciplinary guide-
lines to manage hip or knee OA, recommendations do
differ to some extent.
& The steering group acknowledged the importance of a
patient-centered approach in the management of OA
[23–25]. Therefore, the following elements were con-
sidered to be important and should be incorporated in
the stepped care strategy: mutual goal setting, enhanc-
ing communication between health care providers and
patient, facilitating an active role of the patient while
being realistic about personal limitations as well as the
availability of resources.
& The stepped care strategy presents in step 1 those
interventions that should be offered (or achieved by self
management) to all patients with hip or knee OA. Step
2 or 3 interventions should only be considered for
patients with persisting pain or disability despite use of
interventions from the lower step or steps.
& The stepped care strategy does not provide explicit
statements indicating which specific professional should
be involved, as some treatment options can be delivered
by several health care providers. For example, education
and life style advice can be provided by GPs, nurse
practitioners, occupational therapists or physical therapists
whereas intra-articular injections can be prescribed and
administered by GPs as well as medical specialists.
Discussions and decisions
Comments offered during the different phases of the deve-
lopment process were discussed until consensus was reached.
The major discussions and decisions pertaining to the
three phases are described below.
& Some treatment modalities such as occupational therapy
or braces are at the moment still commonly prescribed
in clinical practice, although they are not recommended
in evidence-based clinical guidelines. For that matter,
the incorporation of these treatment modalities in the
Table 1 Questions presented during the written consultation with 23 representatives
1. Do you agree with the board of the B&JD NL and the members of the national steering group that a more consistent and uniform management
of the treatment for osteoarthritis is desirable?
2. Do you endorse the principles of the stepped care strategy created by the national steering group?
What is your opinion about this draft of stepped care strategy with regard to the following:
3. Is the stepped care strategy clearly formulated?
4. The stepped care strategy consist three steps. Do you think fewer or more steps are desirable?
5. Do you agree with the ranking of the treatment options?
6. Do you endorse the length of the evaluation period proposed for each step?
7. Do you want to add treatment options to this stepped care strategy?
8. Do you believe that specific treatment options mentioned in the stepped care strategy are not relevant? If so, which?
9. Do you believe that implementation of the stepped care strategy will indeed contribute to a more consistent and uniform management of the
treatment of osteoarthritis?
10. Do you have other comments?
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stepped care strategy was discussed. Nevertheless, it
was decided that only treatment modalities that are
recommended in evidence-based clinical guideless
should be included.
& Contrary to the Dutch multidisciplinary guideline for the
diagnosis and management of hip or knee OA, the
international Osteoarthritis Research Society International
(OARSI) guideline recommends the use of topical non-
steroidal anti-inflammatory drugs (NSAIDs) for knee OA
based on a recent meta-analysis of randomized controlled
trials (highest level of evidence, i.e., level 1a) [3].
Therefore, the stepped care strategy recommends the use
of topical NSAIDs as a treatment modality for knee OA.
& The evidence that supports the use of glucosaminesul-
phate is not conclusive. The Dutch multidisciplinary
guideline [1] advices glucosaminesulphate for a trial
period, while the Dutch Guideline for General Practi-
tioners [26, 27] clearly does not advice its use.
Therefore, the stepped care strategy suggests the
possibility of a trial period of 3 months, similar to the
Dutch multidisciplinary guideline. The treatment should
be discontinued if no response is apparent.
& The stepped care strategy should be concise and
straightforward. Therefore, the strategy does not give
recommendations concerning the dosage, assessment of
contra-indications and prevention of side effects of
pharmacological interventions (e.g., of NSAIDs), as
well as those concerning the intensity and content of
non-pharmacological interventions (e.g., physiotherapy).
& The monodisciplinary guideline of the Royal Dutch
Society of Physical Therapy [28] advises restricted use
of Transcutaneous Electrical Nerve Stimulation
(TENS). So, only if exercise therapy and medication
have not resulted in pain reduction, TENS should be
recommended.
Content of the stepped care strategy
The final version of BART presents the optimal order of
non-surgical treatment options for hip or knee OA in three
steps.
Diagnostic procedures and assessment
No definitive test exists to diagnose OA. Therefore, the
diagnosis is primarily based on medical history and physical
examination. In step 2, the stepped care strategy recommends
radiological assessment if there is a discrepancy between the
medical history and physical examination.
Prior to mutual goal setting, health care providers are
advised to assess the nature and the severity of loss in body
functions and body structures as well as reduced activity
and participation resulting from OA. Furthermore, in step 2
behavioural factors that might influence the symptoms and
outcomes of treatment should be assessed.
Treatment modalities
The stepped care strategy implies that the more advanced
options should only be considered if prior options failed.
Therefore, treatment options in step 1, such as education (e.g.,
about the condition, treatment modalities and timing of care),
lifestyle advice (e.g., about exercise, diet, and aids) and an
adequate dose of acetaminophen, should be offered to all
patients with OA. However, they can also be provided through
self-care.
If the treatment options in step 1 are not sufficient,
treatment options in step 2 can be considered: e.g., exercise
therapy, NSAIDs, and tramadol, either alone or in combi-
nation, is recommended. Overweight patients, if motivated
to lose weight, should be referred to a dietician.
Treatment options in step 3, should only to be considered
if those in the previous steps were ineffective. They
comprise the more advanced treatment options, e.g.,
multidisciplinary care, if available. Intra-articular injections
with hyaluronic acid or glucocorticoids or TENS can be
considered in patients with knee OA.
Evaluation
To optimize treatment results, mutual goal setting, systematic
monitoring, evaluation, and if necessary, adjustment to the
previously set goals are advocated.
In step 1, the effectiveness of the treatment should be
evaluated after 3 months. Obviously, if the patient has
persistent symptoms, evaluation can be performed earlier.
In case of partial or non adherence to treatment modalities;
patients’ personal barriers should be identified, and possi-
bilities to improve adherence should be discussed. In step 2,
evaluation should occur after 3–6 months. In step 3, the
evaluation moment should be planned with the patient.
Depending on the setting, different health care providers
such as a nurse practitioner could play an important role in
evaluating and monitoring the treatment. A summary of all
recommendations are shown in Table 2.
Discussion
BART provides a structured approach to achieve imple-
mentation of existing guidelines that emphasize self
management and creates multidisciplinary support to
manage OA. It provides a framework for OA patients and
their health care providers to reduce inadequacies in the
management of non-surgical treatment options, particularly
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utilization and timing of different options. Moreover, the
stepped care strategy endorses quality care as it is built on
evidence-based treatment options for patients with hip or knee
OA. With this instrument, the different health care providers
involved in managing OA and the patients with hip or knee
OA can improve their communication with each other.
A possible limitation of our study is that we did not apply a
generally accepted consensus technique. However, our con-
sensus procedure resembles the nominal group technique and
includes important characteristics of good consensus methods
such as face-to-face meetings, balanced group composition,
feedback, iteration and involvement of experts [29]. Instead of
ranking, all differences in opinions and raised concerns were
resolved by discussion in multiple rounds and after multiple
consultations of experts and patient representative. In our
opinion, the used extensive procedure warrants the quality of
content of the proposed stepped care strategy.
Although the stepped care strategy is based on the Dutch
multidisciplinary guideline, the approach is likely to be also
applicable for other countries, as recommendations in various
national and international guidelines are very similar. In case of
discrepancies, the proposed stepped care strategy can be easily
adjusted. For example, in contrast to the Dutch guideline [1],
the National Institute for Health and Clinical Excellence
(NICE) guideline [4] recommends braces and capsaicin
which could be included in the stepped care strategy.
A possible drawback for such a stepped care approach is
that all patients are initially offered treatment options proposed
in the first step of the model, while more advanced treatment
options, such as joint surgery, may be more appropriate for
patients with advanced OA. However, treatment options
proposed in later steps could be offered, if considered
appropriate. Also, it has been reported that almost half of
the patients referred to secondary care because of OA
benefited from a stepped care approach and no predictors
for response to non-surgical treatment options could be
identified [10]. Therefore, in our opinion, despite the risk for
delay of more advanced treatment, the stepped care strategy
is a suitable approach for patients with knee or hip OA.
We believe that a successful implementation of the
stepped care strategy. BART will improve the outcome and
quality of non-surgical care for patients with hip or knee
OA substantially. Moreover, it will improve the communi-
cation between the patient and the different health care
providers. At this moment, we are implementing BART
strategy in a region in the Netherlands, and will identify
barriers and facilitators for implementing. Therefore, a
number of activities will be employed to inform the
relevant health care providers about the content of the
stepped care strategy, like implementation of a care booklet,
newsletters, scientific articles, meetings and (periodical)
education. Regional working groups play an important role
in contacting and informing their adherents about the
stepped care strategy. Most activities will be performed in
primary care setting.
To facilitate implementation the booklet “Care for
Osteoarthritis” (Zorgwijzer Artrose®) is developed. Besides
providing a patient-friendly version of the stepped care
strategy, this booklet contains concise tools to enhance the
patient’s active role and communication between health
care providers and the patient, such as leaflets to monitor
symptoms, prepare consultations with health care providers,
and draw up a comprehensive overview of the treatment
options that the patient has already tried.
In summary, we developed a stepped care strategy to
optimize the utilization and timing of the non-surgical
Table 2 Summary of the recommendations in each step for the diagnostic procedures and assessment, treatment modalities, and evaluation
Step 1 Step 2 Step 3
Diagnostic procedures
and assessment
- Medical history and
physical examination
- Radiological assessmenta - Consultation specialist
- Assessment function
and activity limitations
- Assessment of pain coping
and psychosocial factors
- Adjust goals
- Setting mutual goals - Adjust goals
Treatment modalities - Education - Exercise therapy - Multidisciplinary care
- Lifestyle advice - Dietary therapy - TENS
- Medicationb - Medicationb - Medicationb
• Acetaminophen • (Topical) NSAIDs • Intra-articular injections
• Glucosaminesulphate • Tramadol
Evaluation - After 3 monthsc - After 3–6 monthsc - Patient sets interval
a If there is a discrepancy between medical history and physical examination
b Consult current guidelines for an adequate dose [1, 27]
c Or earlier, if the symptoms persist or increase
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treatment options for patients with osteoarthritis of hip or knee.
Because osteoarthritis is a heterogeneous and longstanding
disease, possible benefits of the proposed model of care will
only pay off in the long term. Therefore, long-term prospective
studies are needed to evaluate its cost-effectiveness.
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